Predicate |
Object |
contentType |
Comment|Letter |
endingPage |
6 |
issn |
0959-8138 |
issueIdentifier |
7306 |
pageRange |
233; author reply 235-6 |
publicationName |
BMJ (Clinical research ed.) |
startingPage |
233; author reply 235 |
bibliographicCitation |
Cleland JG, Kaye GC. Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation. BMJ. 2001 Jul 28;323(7306):233; author reply 235–6. PMID: 11496885; PMCID: PMC1120847. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5dfd86b18d8c46ade1eaa72c2e15125 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2350cc6b6466d483c64996496f520f6 |
date |
2001-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/11496885 https://pubmed.ncbi.nlm.nih.gov/PMC1120847 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2274 https://portal.issn.org/resource/ISSN/0959-8138 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ |
title |
Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation |
discusses |
http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0022871 http://id.nlm.nih.gov/mesh/M0001380 http://id.nlm.nih.gov/mesh/M0017012 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D020521Q000517 http://id.nlm.nih.gov/mesh/D001281Q000188 http://id.nlm.nih.gov/mesh/D000925Q000627 http://id.nlm.nih.gov/mesh/D014859Q000627 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D015201 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 |